Literature DB >> 25053781

Featured article: induction of heme oxygenase with hemin improves pericardial adipocyte morphology and function in obese Zucker rats by enhancing proteins of regeneration.

Joseph Fomusi Ndisang1, Shuchita Tiwari2.   

Abstract

Oxidative stress and inflammation are implicated in tissue remodeling, hypertrophy, and organ malfunction. Since heme-oxygenase (HO) is a cytoprotective enzyme with effects against oxidative stress and inflammation, we investigated the effects of upregulating HO with hemin on adipocyte hypertrophy, proteins of repair/regeneration including beta-catenin, Oct3/4 and Pax2 as well as pro-fibrotic/remodeling proteins like osteopontin and transforming growth factor-beta (TGF-β) in pericardial adipose tissue from obese Zucker rats (ZRs). Treatment with hemin significantly reduced pericardial adipose tissue inflammation/oxidative stress, suppressed osteopontin and TGF-β, and attenuated pericardial adipocyte hypertrophy in obese ZRs. These were associated with enhanced expression of the stem/progenitor-cell marker cKit; the potentiation of several proteins of regeneration including beta-catenin, Oct3/4, Pax2; and improved pericardial adipocyte morphology. Interestingly, the amelioration of adipocyte hypertrophy in hemin-treated animals was accompanied by improved adipocyte function, evidenced by increased levels of pericardial adipose tissue adiponectin. Furthermore, hemin significantly reduced hypertriglyceridemia and hypercholesteromia in obese ZRs. The protective effects of hemin were accompanied by robust potentiation HO activity and the total antioxidant capacity, whereas the co-administration of hemin with the HO inhibitor, stannous mesoporphyrin abolished the effects of hemin. These data suggest that hemin improves pericardial adipocyte morphology and function by enhancing proteins of repair and regeneration, while concomitantly abating inflammatory/oxidative insults and suppressing extracellular-matrix/profibrotic and remodeling proteins. The reduction of hypertriglyceridemia, hypercholesteromia, pericardial adiposity, and pericardial adipocyte hypertrophy with corresponding improvement of adipocyte morphology/function in hemin-treated animals suggests that HO inducers may be explored for the design of novel remedies against cardiac complications arising from excessive adiposity.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Inflammation; adipocytes; adiponectin; heme oxygenase; obesity; oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25053781      PMCID: PMC4935191          DOI: 10.1177/1535370214544268

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  63 in total

1.  Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.

Authors:  X Shi; S Bai; L Li; X Cao
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

2.  Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.

Authors:  He Huang; Qi-Zhu Tang; Ai-Bing Wang; Manyin Chen; Ling Yan; Chen Liu; Hong Jiang; Qinglin Yang; Zhou-Yan Bian; Xue Bai; Li-Hua Zhu; Lang Wang; Hongliang Li
Journal:  Hypertension       Date:  2010-06-28       Impact factor: 10.190

3.  8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.

Authors:  N Delanty; M P Reilly; D Pratico; J A Lawson; J F McCarthy; A E Wood; S T Ohnishi; D J Fitzgerald; G A FitzGerald
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

4.  Losartan improves adipose tissue-derived stem cell niche by inhibiting transforming growth factor-β and fibrosis in skeletal muscle injury.

Authors:  Jin-Kyu Park; Mi-Ran Ki; Eun-Mi Lee; Ah-Young Kim; Sang-Young You; Seon-Young Han; Eun-Joo Lee; Il-Hwa Hong; Soon-Hak Kwon; Seong-Jin Kim; Thomas A Rando; Kyu-Shik Jeong
Journal:  Cell Transplant       Date:  2012-04-10       Impact factor: 4.064

5.  Alterations in heme oxygenase/carbon monoxide system in pulmonary arteries in hypertension.

Authors:  Joseph Fomusi Ndisang; Rui Wang
Journal:  Exp Biol Med (Maywood)       Date:  2003-05

6.  Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function.

Authors:  Maximilian Zeyda; Karina Gollinger; Jelena Todoric; Florian W Kiefer; Maike Keck; Oskar Aszmann; Gerhard Prager; Gerhard J Zlabinger; Peter Petzelbauer; Thomas M Stulnig
Journal:  Endocrinology       Date:  2011-04-05       Impact factor: 4.736

Review 7.  Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

Authors:  G M Reaven
Journal:  Panminerva Med       Date:  2005-12       Impact factor: 5.197

8.  Nitrotyrosine as an oxidative stress marker: evidence for involvement in neurologic outcome in human traumatic brain injury.

Authors:  Ribal S Darwish; Nana Amiridze; Bizhan Aarabi
Journal:  J Trauma       Date:  2007-08

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  The risk of heart failure and cardiometabolic complications in obesity may be masked by an apparent healthy status of normal blood glucose.

Authors:  Shuchita Tiwari; Manish Mishra; Ashok Jadhav; Courtney Gerger; Paul Lee; Lynn Weber; Joseph Fomusi Ndisang
Journal:  Oxid Med Cell Longev       Date:  2013-12-14       Impact factor: 6.543

View more
  2 in total

1.  Induction of heme oxygenase-1 with hemin reduces obesity-induced adipose tissue inflammation via adipose macrophage phenotype switching.

Authors:  Thai Hien Tu; Yeonsoo Joe; Hye-Seon Choi; Hun Taeg Chung; Rina Yu
Journal:  Mediators Inflamm       Date:  2014-11-11       Impact factor: 4.711

2.  N-acetylcysteine Provides Cytoprotection in Murine Oligodendrocytes through Heme Oxygenase-1 Activity.

Authors:  Jie Zhou; Marcia R Terluk; Lisa Basso; Usha R Mishra; Paul J Orchard; James C Cloyd; Henning Schröder; Reena V Kartha
Journal:  Biomedicines       Date:  2020-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.